Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

Preliminary phase II data on Xoma's Neuprex in trauma

March 3, 1997

FDA advisory panel approves carvedilol

March 3, 1997

Posicor recommended for approval in the U.S.

March 3, 1997

Symphar/SKB disclose compounds with Lp(a)-lowering activity

March 3, 1997

New clinical results for Cypros' CPC-111

Feb. 28, 1997

Positive results reported for VasoCare in MI

Feb. 27, 1997

Harvard College discloses vascular injury-associated gene

Feb. 27, 1997

Cytel and Sumitomo expand agreement

Feb. 26, 1997

Bayer and Zeneca to comarket Ca antagonist

Feb. 26, 1997

Adenosine antagonists claimed by Fujisawa

Feb. 26, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...